CDC20 and melanoma: Using the same method, we have also demonstrated in melanoma that cardiomyocyte-specific overexpression of CDC20 significantly inhibits DOX-induced myocardial injury, not affecting the antitumor effect of DOX (Supplementary Fig. S10).